Published in World J Hepatol on March 27, 2010
Human Schistosomiasis mansoni associated with hepatocellular carcinoma in Egypt: current perspective. J Parasit Dis (2014) 0.88
Targeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patients. World J Hepatol (2015) 0.83
Disease monitoring of hepatocellular carcinoma through metabolomics. World J Hepatol (2017) 0.75
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol (2001) 19.07
Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet (2002) 7.67
Hepatocellular carcinoma: recent trends in the United States. Gastroenterology (2004) 5.90
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res (2004) 5.68
New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res (2005) 4.47
Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis. Ann Intern Med (2003) 2.51
Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. Arch Intern Med (1997) 2.33
Chronic hepatitis: morphology and nomenclature. Mod Pathol (1994) 1.64
Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis. Am J Gastroenterol (2007) 1.49
The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma. Cancer Res (2004) 1.30
Influence of liver cancer on lipid and lipoprotein metabolism. Lipids Health Dis (2006) 1.23
The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population. Clin Gastroenterol Hepatol (2007) 1.13
The degree of readiness of selected biomarkers for the early detection of hepatocellular carcinoma: notes from a recent workshop. Cancer Biomark (2008) 1.01
The hepatitis B virus X protein inhibits secretion of apolipoprotein B by enhancing the expression of N-acetylglucosaminyltransferase III. J Biol Chem (2004) 1.00
Lipid parameters predicting liver function in patients with cirrhosis and after liver transplantation. Hepatogastroenterology (1999) 0.99
Serum lipids in hepatoma. Oncology (1979) 0.97
Clinical significance of abnormal lipoprotein patterns in liver diseases. Int J Mol Med (2005) 0.96
Proteomics: recent applications and new technologies. Basic Clin Pharmacol Toxicol (2006) 0.95
Lipoprotein (a) behaviour in patients with hepatocellular carcinoma. Minerva Med (2001) 0.92
Proteomics for hepatocellular carcinoma marker discovery. Gastroenterology (2004) 0.91
Low lipoprotein (a) levels during acute viral hepatitis. Hepatology (1996) 0.89
Toward the discovery of new biomarkers of hepatocellular carcinoma by proteomics. Liver Int (2007) 0.88
Lipoprotein (a) serum levels in patients with hepatocarcinoma. Clin Chim Acta (1997) 0.84
Oxidation of specific methionine and tryptophan residues of apolipoprotein A-I in hepatocarcinogenesis. Proteomics (2005) 0.83
Mechanisms and significance of lipoprotein(a) in hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int (2009) 0.80
Evidence-based diagnosis and locoregional therapy for hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol (2008) 0.78
Multiple links between transcription and splicing. RNA (2004) 4.90
DNA damage regulates alternative splicing through inhibition of RNA polymerase II elongation. Cell (2009) 3.66
Control of alternative splicing through siRNA-mediated transcriptional gene silencing. Nat Struct Mol Biol (2009) 3.47
The transcriptional cycle of HIV-1 in real-time and live cells. J Cell Biol (2007) 2.69
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C. J Hepatol (2013) 2.63
Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation. J Hepatol (2003) 2.35
Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology (2013) 2.08
A prospective study of the efficacy of clinical application of a new carrier-bound fibrin sealant after liver resection. Arch Surg (2010) 1.88
Acute liver failure in Spain: analysis of 267 cases. Liver Transpl (2007) 1.71
The carboxy terminal domain of RNA polymerase II and alternative splicing. Trends Biochem Sci (2010) 1.67
Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis. Liver Transpl (2009) 1.55
Effect of internal biliary drainage on plasma levels of endotoxin, cytokines, and C-reactive protein in patients with obstructive jaundice. World J Surg (2002) 1.47
Cardiotrophin-1 reduces ischemia/reperfusion injury during liver transplant. J Surg Res (2012) 1.45
Comparative Short-term Benefits of Laparoscopic Liver Resection: 9000 Cases and Climbing. Ann Surg (2016) 1.06
Role of serum cytokine profile in ulcerative colitis assessment. Inflamm Bowel Dis (2012) 1.05
Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFα. Arthritis Res Ther (2015) 1.00
N-acetylcysteine, coenzyme Q10 and superoxide dismutase mimetic prevent mitochondrial cell dysfunction and cell death induced by d-galactosamine in primary culture of human hepatocytes. Chem Biol Interact (2009) 0.96
Can we expand the indications for laparoscopic liver resection? A systematic review and meta-analysis of laparoscopic liver resection for patients with hepatocellular carcinoma and chronic liver disease. J Hepatobiliary Pancreat Sci (2015) 0.93
Cardiovascular risk in systemic autoimmune diseases: epigenetic mechanisms of immune regulatory functions. Clin Dev Immunol (2011) 0.92
Nuclear translocation of β-catenin during mesenchymal stem cells differentiation into hepatocytes is associated with a tumoral phenotype. PLoS One (2012) 0.92
Unraveling the S-nitrosoproteome: tools and strategies. Proteomics (2009) 0.90
Control of alternative pre-mRNA splicing by RNA Pol II elongation: faster is not always better. IUBMB Life (2003) 0.88
BNP as marker of heart dysfunction in patients with liver cirrhosis. Eur J Gastroenterol Hepatol (2010) 0.88
Global effects of fluvastatin on the prothrombotic status of patients with antiphospholipid syndrome. Ann Rheum Dis (2010) 0.86
Efficacy of the retreatment of hepatitis C virus infections after liver transplantation: role of an aggressive approach. Liver Transpl (2013) 0.84
[Diagnosis and treatment of hepatocellular carcinoma]. Med Clin (Barc) (2009) 0.84
Strategies to reduce hepatitis C virus recurrence after liver transplantation. World J Hepatol (2013) 0.82
Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C. Cochrane Database Syst Rev (2013) 0.82
Prediction of graft dysfunction based on extended criteria donors in the model for end-stage liver disease score era. Transplantation (2010) 0.82
PGE1-induced NO reduces apoptosis by D-galactosamine through attenuation of NF-kappaB and NOS-2 expression in rat hepatocytes. Hepatology (2004) 0.82
Donor-recipient matching: myths and realities. J Hepatol (2012) 0.81
[Treatment approach of hepatocellular carcinoma in Spain. Analysis of 705 patients from 62 centers]. Med Clin (Barc) (2009) 0.81
Mitochondrial dysfunction in antiphospholipid syndrome: implications in the pathogenesis of the disease and effects of coenzyme Q(10) treatment. Blood (2012) 0.80
To cardiovascular disease and beyond: new therapeutic perspectives of statins in autoimmune diseases and cancer. Curr Drug Targets (2012) 0.79
Potential use of statins in the treatment of antiphospholipid syndrome. Curr Rheumatol Rep (2012) 0.78
AEE788 is a vascular endothelial growth factor receptor tyrosine kinase inhibitor with antiproliferative and proapoptotic effects in acute myeloid leukemia. Exp Hematol (2010) 0.78
Late hepatic artery pseudoaneurysm: a rare complication after resection of hilar cholangiocarcinoma. World J Gastroenterol (2008) 0.78
Acute liver failure in a patient with multiple sclerosis treated with interferon-beta. Mult Scler (2007) 0.77
The reduction of cell death and proliferation by p27(Kip1) minimizes DNA damage in an experimental model of genotoxicity. Int J Cancer (2009) 0.77
Additive effect of PTK787/ZK 222584, a potent inhibitor of VEGFR phosphorylation, with Idarubicin in the treatment of acute myeloid leukemia. Exp Hematol (2009) 0.76
Control of blood pressure in liver transplant recipients. Transplantation (2012) 0.75
Usage of adenovirus expressing thymidine kinase mediated hepatocellular damage for enabling mouse liver repopulation with allogenic or xenogenic hepatocytes. PLoS One (2013) 0.75
Extended criteria donors in liver transplant candidates with hepatorenal syndrome. Clin Transplant (2011) 0.75
[The Spanish System of Accreditation of Professional Competencies in Hepatology. A proposal of the Spanish Association for the Study of the Liver]. Gastroenterol Hepatol (2008) 0.75
Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver Transplantation. Transplantation (2016) 0.75
Human mesenchymal stromal cell lysates as a novel strategy to recover liver function. Regen Med (2015) 0.75
Predicting patient survival after liver transplantation using evolutionary multi-objective artificial neural networks. Artif Intell Med (2013) 0.75
Controlling Diabetes After Liver Transplantation: Room for Improvement. Transplantation (2016) 0.75
The Southampton Consensus Guidelines for Laparoscopic Liver Surgery: From Indication to Implementation. Ann Surg (2017) 0.75